Oxford Gene Technology (OGT) and Applied Microarrays Inc (AMI) have announced the completion of a licence agreement granting AMI access to OGT’s “Southern array patents”, the fundamental patents covering the manufacture and marketing of oligonucleotide microarrays.
Applied Microarrays Inc., who recently acquired Codelink technology from GE Healthcare, are now licensed to fabricate, market and distribute Codelink microarrays worldwide.
In addition, this license grants OEM rights allowing AMI to manufacture custom microarrays for third parties under their own brand name. All microarrays fabricated by AMI include rights for their use within Service organisations.
Sue Sutton, Vice President Licensing North America, at OGT said: “This license agreement is important in that it will ensure the continued supply of Codelink microarrays to the market and gives companies without their own microarray fabrication facility the opportunity to add microarrays to their product portfolio”.
The licence will remain valid for the patents’ lifetime. Financial details were not disclosed.